Table 1.
Clinicopathologic characteristics of hepatocellular carcinoma patients with low and high expression of G9a.
| Parameter | G9a Low | G9a High | p-Value |
|---|---|---|---|
| Chi-Squared | |||
| Age (years) | 60.3 ± 12.7 | 62.2 ± 11.6 | |
| Sex, no. of patients | |||
| Male | 66 | 80 | 0.3303 |
| Female | 14 | 10 | |
| Tumor size | |||
| <5 cm | 53 | 52 | 0.3288 |
| >5 cm | 27 | 38 | |
| Stage | |||
| I or II | 61 | 65 | 0.6723 |
| III or IV | 19 | 25 | |
| Portal vein involvement | |||
| No | 72 | 79 | 0.8296 |
| Yes | 8 | 11 | |
| α-Fetoprotein (ng/mL) | |||
| 0–500 | 67 | 66 | 0.0916 |
| >500 | 11 | 23 | |
| Microvessel invasion | |||
| No | 31 | 29 | 0.4665 |
| Yes | 49 | 61 | |
| Cirrhosis | |||
| No | 51 | 42 | 0.0507 |
| Yes | 28 | 45 | |
| Hepatitis B virus status | |||
| Negative | 25 | 30 | 0.9449 |
| Positive | 54 | 60 | |
| Hepatitis C virus status | |||
| Negative | 61 | 66 | 0.6860 |
| Positive | 18 | 24 |